These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16247041)

  • 21. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
    J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of cerebral artery recanalization in patients with stroke with and without neurological improvement after intravenous thrombolysis.
    Kharitonova TV; Melo TP; Andersen G; Egido JA; Castillo J; Wahlgren N;
    Stroke; 2013 Sep; 44(9):2513-8. PubMed ID: 23881960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NIHSS-time score easily predicts outcomes in rt-PA patients: the SAMURAI rt-PA registry.
    Aoki J; Kimura K; Koga M; Kario K; Nakagawara J; Furui E; Shiokawa Y; Hasegawa Y; Okuda S; Yamagami H; Okada Y; Shibazaki K; Sakamoto Y; Toyoda K
    J Neurol Sci; 2013 Apr; 327(1-2):6-11. PubMed ID: 23433814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
    Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
    Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study.
    Saqqur M; Molina CA; Salam A; Siddiqui M; Ribo M; Uchino K; Calleja S; Garami Z; Khan K; Akhtar N; O'Rourke F; Shuaib A; Demchuk AM; Alexandrov AV;
    Stroke; 2007 Jan; 38(1):69-74. PubMed ID: 17138949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of lesion side on acute stroke treatment.
    Di Legge S; Fang J; Saposnik G; Hachinski V
    Neurology; 2005 Jul; 65(1):81-6. PubMed ID: 16009890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of aphasia in stroke patients early after iv thrombolysis.
    Kremer C; Perren F; Kappelin J; Selariu E; Abul-Kasim K
    Clin Neurol Neurosurg; 2013 Mar; 115(3):289-92. PubMed ID: 22738732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study.
    Messé SR; Kasner SE; Cucchiara BL; Demchuk A; Tanne D; Ouyang B; Levine SR;
    J Stroke Cerebrovasc Dis; 2011; 20(3):236-40. PubMed ID: 20656508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining minor symptoms in acute ischemic stroke.
    Strambo D; Zambon AA; Roveri L; Giacalone G; Di Maggio G; Peruzzotti-Jametti L; La Gioia S; Galantucci S; Comi G; Sessa M
    Cerebrovasc Dis; 2015; 39(3-4):209-15. PubMed ID: 25791530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of early National Institutes of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke.
    Kharitonova T; Mikulik R; Roine RO; Soinne L; Ahmed N; Wahlgren N;
    Stroke; 2011 Jun; 42(6):1638-43. PubMed ID: 21512176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
    Nam HS; Lee KY; Han SW; Kim SH; Lee JY; Ahn SH; Kim DJ; Kim DI; Nam CM; Heo JH
    J Neurol Sci; 2009 Jun; 281(1-2):69-73. PubMed ID: 19304298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.
    Matsuo R; Kamouchi M; Ago T; Hata J; Shono Y; Kuroda J; Wakisaka Y; Sugimori H; Kitazono T;
    Geriatr Gerontol Int; 2014 Oct; 14(4):954-9. PubMed ID: 24320947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
    Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of telemedicine on acute management of stroke patients undergoing endovascular procedures.
    Pedragosa A; Alvarez-Sabín J; Rubiera M; Rodriguez-Luna D; Maisterra O; Molina C; Brugués J; Ribó M
    Cerebrovasc Dis; 2012; 34(5-6):436-42. PubMed ID: 23207552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S; Toni D;
    Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.